company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:08:12+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,5650000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:08:12+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,5650000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:08:12+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2811000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:08:12+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2811000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:08:12+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2839000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:08:12+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,366000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:08:12+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,958000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:08:12+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,432000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:08:12+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-72000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:08:12+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,240000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:08:12+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,20000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:08:12+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1944000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:08:12+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,895000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:08:12+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-207000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:08:12+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-207000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:08:12+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,688000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:08:12+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,54000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:08:12+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,7000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:08:12+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,641000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:08:12+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,641000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:08:12+00:00,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,65000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:08:12+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-4000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:08:12+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,580000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:08:12+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1016000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:08:12+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.57
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:08:12+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1017500000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:08:12+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.57
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:08:12+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1017500000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:08:12+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.57
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 16:04:31+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,5720000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 16:04:31+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,5720000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 16:04:31+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2865000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 16:04:31+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2865000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 16:04:31+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2855000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 16:04:31+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,363000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 16:04:31+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,944000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 16:04:31+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,469000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 16:04:31+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-24000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 16:04:31+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,6519000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 16:04:31+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,324000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 16:04:31+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,8595000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 16:04:31+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-5740000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 16:04:31+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-238000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 16:04:31+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-238000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 16:04:31+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-5978000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 16:04:31+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-22000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 16:04:31+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-14000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 16:04:31+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5970000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 16:04:31+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5970000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 16:04:31+00:00,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,65000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 16:04:31+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-6035000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 16:04:31+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1017000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 16:04:31+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-5.94
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 16:04:31+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1017000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 16:04:31+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-5.94
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 16:04:31+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1016000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 16:04:31+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-5.94
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q3,2017-07-01,2017-09-30,2018-11-01 16:07:31+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,5617000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q3,2017-07-01,2017-09-30,2018-11-01 16:07:31+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,5617000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q3,2017-07-01,2017-09-30,2018-11-01 16:07:31+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2967000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q3,2017-07-01,2017-09-30,2018-11-01 16:07:31+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2967000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q3,2017-07-01,2017-09-30,2018-11-01 16:07:31+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2650000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q3,2017-07-01,2017-09-30,2018-11-01 16:07:31+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,372000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q3,2017-07-01,2017-09-30,2018-11-01 16:07:31+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,843000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q3,2017-07-01,2017-09-30,2018-11-01 16:07:31+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,531000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q3,2017-07-01,2017-09-30,2018-11-01 16:07:31+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-4000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q3,2017-07-01,2017-09-30,2018-11-01 16:07:31+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,550000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q3,2017-07-01,2017-09-30,2018-11-01 16:07:31+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,-20000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q3,2017-07-01,2017-09-30,2018-11-01 16:07:31+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2272000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q3,2017-07-01,2017-09-30,2018-11-01 16:07:31+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,378000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q3,2017-07-01,2017-09-30,2018-11-01 16:07:31+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-259000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q3,2017-07-01,2017-09-30,2018-11-01 16:07:31+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-259000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q3,2017-07-01,2017-09-30,2018-11-01 16:07:31+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,119000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q3,2017-07-01,2017-09-30,2018-11-01 16:07:31+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-494000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q3,2017-07-01,2017-09-30,2018-11-01 16:07:31+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-3000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q3,2017-07-01,2017-09-30,2018-11-01 16:07:31+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,610000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q3,2017-07-01,2017-09-30,2018-11-01 16:07:31+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,610000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q3,2017-07-01,2017-09-30,2018-11-01 16:07:31+00:00,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,65000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q3,2017-07-01,2017-09-30,2018-11-01 16:07:31+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,15000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q3,2017-07-01,2017-09-30,2018-11-01 16:07:31+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,530000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q3,2017-07-01,2017-09-30,2018-11-01 16:07:31+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1017000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q3,2017-07-01,2017-09-30,2018-11-01 16:07:31+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.52
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q3,2017-07-01,2017-09-30,2018-11-01 16:07:31+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1017000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q3,2017-07-01,2017-09-30,2018-11-01 16:07:31+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.52
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q3,2017-07-01,2017-09-30,2018-11-01 16:07:31+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1019200000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q3,2017-07-01,2017-09-30,2018-11-01 16:07:31+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.52
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q4,2017-10-01,2017-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4866000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q4,2017-10-01,2017-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4866000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q4,2017-10-01,2017-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2594000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q4,2017-10-01,2017-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2594000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2271000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,350000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,650000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,346000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-1099000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,13029000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,1836000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,176000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,15288000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-13017000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-191000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-191000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-13208000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-1471000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,7000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q4,2017-10-01,2017-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-11730000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q4,2017-10-01,2017-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-11730000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q4,2017-10-01,2017-12-31,,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,65000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q4,2017-10-01,2017-12-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-195000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q4,2017-10-01,2017-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-11600000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q4,2017-10-01,2017-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1016000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q4,2017-10-01,2017-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-11.41
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q4,2017-10-01,2017-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1016000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q4,2017-10-01,2017-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-11.41
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q4,2017-10-01,2017-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1016300000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q4,2017-10-01,2017-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-11.41
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2017.0,Q4,2017-10-01,2017-12-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.85
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 16:02:39+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,5065000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 16:02:39+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,5065000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 16:02:39+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2750000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 16:02:39+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2750000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 16:02:39+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2315000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 16:02:39+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,329000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 16:02:39+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,738000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 16:02:39+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,317000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 16:02:39+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-203000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 16:02:39+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,887000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 16:02:39+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,-1278000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 16:02:39+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,790000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 16:02:39+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1525000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 16:02:39+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-271000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 16:02:39+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-271000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 16:02:39+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1254000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 16:02:39+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,46000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 16:02:39+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-74000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 16:02:39+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1134000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 16:02:39+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1134000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 16:02:39+00:00,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,65000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 16:02:39+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,14000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 16:02:39+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1055000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 16:02:39+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1017000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 16:02:39+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.04
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 16:02:39+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1020000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 16:02:39+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.03
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 16:02:39+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1014400000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 16:02:39+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.04
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:08:11+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4701000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:08:11+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4701000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:08:11+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2668000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:08:11+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2668000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:08:11+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2033000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:08:11+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,316000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:08:11+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,682000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:08:11+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,290000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:08:11+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-96000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:08:11+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,835000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:08:11+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,20000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:08:11+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2047000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:08:11+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-14000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:08:11+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-236000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:08:11+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-236000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:08:11+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-250000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:08:11+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-76000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:08:11+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,8000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:08:11+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-166000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:08:11+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-166000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:08:11+00:00,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,65000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:08:11+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,10000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:08:11+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-241000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:08:11+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1018000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:08:11+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.24
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:08:11+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1018000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:08:11+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.24
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:08:11+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1004200000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:08:11+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.24
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:04:19+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4529000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:04:19+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4529000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:04:19+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2552000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:04:19+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2552000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:04:19+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1977000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:04:19+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,309000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:04:19+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,699000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:04:19+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,311000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:04:19+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-35000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:04:19+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,658000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:04:19+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,19000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:04:19+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1961000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:04:19+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,16000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:04:19+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-229000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:04:19+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-229000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:04:19+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-213000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:04:19+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-26000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:04:19+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-10000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:04:19+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-197000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:04:19+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-197000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:04:19+00:00,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,65000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:04:19+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,11000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:04:19+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-273000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:04:19+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1018000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:04:19+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.27
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:04:19+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1018000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:04:19+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.27
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:04:19+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1011100000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:04:19+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.27
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q4,2018-10-01,2018-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3976000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q4,2018-10-01,2018-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3976000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q4,2018-10-01,2018-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2005000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q4,2018-10-01,2018-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2005000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1971000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,344000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,797000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,295000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,43000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,2638000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,987000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,31000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,5135000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q4,2018-10-01,2018-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-3164000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-223000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q4,2018-10-01,2018-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-223000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-3387000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-139000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,5000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q4,2018-10-01,2018-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-3243000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q4,2018-10-01,2018-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-3243000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q4,2018-10-01,2018-12-31,,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,54000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q4,2018-10-01,2018-12-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-357000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q4,2018-10-01,2018-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-2940000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q4,2018-10-01,2018-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1021000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q4,2018-10-01,2018-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-2.88
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q4,2018-10-01,2018-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1021000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q4,2018-10-01,2018-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-2.87
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q4,2018-10-01,2018-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1020900000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2018.0,Q4,2018-10-01,2018-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-2.88
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:07:31+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4149000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:07:31+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4149000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:07:31+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2293000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:07:31+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2293000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:07:31+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1856000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:07:31+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,292000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:07:31+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,648000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:07:31+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,261000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:07:31+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-6000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:07:31+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,470000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:07:31+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,57000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:07:31+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1722000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:07:31+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,134000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:07:31+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-218000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:07:31+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-218000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:07:31+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-84000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:07:31+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,9000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:07:31+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-4000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:07:31+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-97000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:07:31+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-97000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:07:31+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,8000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:07:31+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-105000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:07:31+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1090000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:07:31+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.1
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:07:31+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1090000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:07:31+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.1
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:07:31+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,-1050000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:07:31+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.1
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:08:11+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4337000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:08:11+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4337000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:08:11+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2443000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:08:11+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2443000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:08:11+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1893000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:08:11+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,296000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:08:11+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,666000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:08:11+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,276000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:08:11+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-9000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:08:11+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,662000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:08:11+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,646000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:08:11+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2537000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:08:11+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-644000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:08:11+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-206000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:08:11+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-206000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:08:11+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-850000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:08:11+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-179000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:08:11+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-671000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:08:11+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-671000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:08:11+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,18000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:08:11+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-689000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:08:11+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1092000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:08:11+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.63
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:08:11+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1092000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:08:11+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.63
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:08:11+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1093700000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:08:11+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.63
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:04:19+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4264000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:04:19+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4264000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:04:19+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2435000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:04:19+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2435000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:04:19+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1830000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:04:19+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,285000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:04:19+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,595000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:04:19+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,240000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:04:19+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-14000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:04:19+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,337000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:04:19+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,468000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:04:19+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1911000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:04:19+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-81000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:04:19+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-211000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:04:19+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-211000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:04:19+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-292000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:04:19+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,11000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:04:19+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-4000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:04:19+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-307000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:04:19+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-307000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:04:19+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,7000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:04:19+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-314000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:04:19+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1092000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:04:19+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.29
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:04:19+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1092000000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:04:19+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.29
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:04:19+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1082800000.0
Teva Pharmaceutical Industries Ltd,TEVA,549300BAFGM4RC74ZJ94,0000818686,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:04:19+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.29
